Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MGTX |
---|---|---|
09:32 ET | 1034 | 5.86 |
09:33 ET | 1300 | 5.85 |
09:35 ET | 100 | 5.8846 |
09:42 ET | 1900 | 5.8001 |
09:44 ET | 7591 | 5.82 |
09:50 ET | 4100 | 5.8003 |
09:51 ET | 655 | 5.8 |
09:53 ET | 200 | 5.81 |
09:55 ET | 300 | 5.79 |
09:57 ET | 300 | 5.83 |
10:00 ET | 100 | 5.83 |
10:04 ET | 4436 | 5.82 |
10:06 ET | 330 | 5.79 |
10:08 ET | 1000 | 5.7897 |
10:11 ET | 4200 | 5.81 |
10:13 ET | 100 | 5.82 |
10:15 ET | 994 | 5.845 |
10:18 ET | 1500 | 5.85 |
10:20 ET | 1410 | 5.86 |
10:22 ET | 700 | 5.86 |
10:29 ET | 800 | 5.84 |
10:33 ET | 100 | 5.81 |
10:49 ET | 100 | 5.86 |
10:54 ET | 200 | 5.88 |
11:03 ET | 415 | 5.89 |
11:05 ET | 100 | 5.87 |
11:16 ET | 200 | 5.88 |
11:21 ET | 100 | 5.905 |
11:23 ET | 100 | 5.89 |
11:25 ET | 100 | 5.92 |
11:27 ET | 122 | 5.91 |
11:30 ET | 3250 | 5.95 |
11:32 ET | 268 | 5.94 |
11:34 ET | 200 | 5.91 |
11:36 ET | 100 | 5.93 |
11:39 ET | 268 | 5.94 |
11:41 ET | 500 | 5.9039 |
11:43 ET | 139 | 5.9 |
11:48 ET | 100 | 5.92 |
11:50 ET | 927 | 5.91 |
11:52 ET | 200 | 5.91 |
11:59 ET | 100 | 5.93 |
12:08 ET | 1889 | 5.96 |
12:12 ET | 300 | 5.9707 |
12:15 ET | 1100 | 5.96 |
12:17 ET | 659 | 5.95 |
12:19 ET | 1500 | 5.932 |
12:21 ET | 7802 | 5.97 |
12:24 ET | 300 | 5.99 |
12:28 ET | 1000 | 5.9726 |
12:30 ET | 3860 | 5.97 |
12:44 ET | 575 | 6.005 |
12:46 ET | 300 | 6 |
12:50 ET | 100 | 6.02 |
12:51 ET | 415 | 6 |
01:00 ET | 267 | 5.99 |
01:02 ET | 300 | 5.99 |
01:08 ET | 300 | 5.99 |
01:09 ET | 2100 | 5.98 |
01:18 ET | 202 | 5.98 |
01:24 ET | 100 | 6 |
01:27 ET | 515 | 6.01 |
01:31 ET | 100 | 6 |
01:38 ET | 100 | 5.9902 |
01:42 ET | 800 | 5.99 |
01:49 ET | 300 | 5.97 |
02:05 ET | 400 | 5.96 |
02:09 ET | 3956 | 5.93 |
02:12 ET | 500 | 5.91 |
02:14 ET | 1000 | 5.8943 |
02:20 ET | 300 | 5.88 |
02:21 ET | 300 | 5.88 |
02:23 ET | 3055 | 5.88 |
02:25 ET | 200 | 5.89 |
02:27 ET | 100 | 5.9 |
02:30 ET | 100 | 5.91 |
02:34 ET | 200 | 5.9 |
02:36 ET | 865 | 5.915 |
02:38 ET | 100 | 5.92 |
02:39 ET | 700 | 5.91 |
02:41 ET | 200 | 5.9 |
02:50 ET | 300 | 5.88 |
02:52 ET | 100 | 5.88 |
02:54 ET | 800 | 5.88 |
02:56 ET | 100 | 5.88 |
02:57 ET | 410 | 5.87 |
03:06 ET | 800 | 5.86 |
03:08 ET | 300 | 5.87 |
03:14 ET | 1717 | 5.88 |
03:19 ET | 900 | 5.89 |
03:37 ET | 396 | 5.885 |
03:42 ET | 300 | 5.89 |
03:46 ET | 100 | 5.9019 |
03:48 ET | 300 | 5.9 |
03:50 ET | 3732 | 5.9099 |
03:51 ET | 1400 | 5.91 |
03:53 ET | 400 | 5.91 |
03:55 ET | 594 | 5.93 |
03:57 ET | 2737 | 5.91 |
04:00 ET | 24764 | 5.92 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
MeiraGTx Holdings PLC | 456.9M | -4.6x | --- |
Taysha Gene Therapies Inc | 446.8M | -34.9x | --- |
ProQR Therapeutics NV | 382.3M | -11.7x | --- |
4D Molecular Therapeutics Inc | 415.2M | -2.9x | --- |
Kalvista Pharmaceuticals Inc | 457.7M | -2.6x | --- |
Verve Therapeutics Inc | 389.5M | -1.9x | --- |
MeiraGTx Holdings PLC is a vertically integrated, clinical-stage gene therapy company. The Company is focused on three distinct areas of unmet medical need: ocular diseases, including inherited retinal diseases (IRDs), as well as large degenerative ocular diseases, severe forms of xerostomia and neurodegenerative diseases. Its product pipeline includes botaretigene sparoparvovec or bota-vec, for the treatment of X-linked retinitis pigmentosa related to mutations in the retinitis pigmentosa GTPase regulator gene or XLRP-RPGR; AAV-hAQP1 for the treatment of radiation-induced Grade 2/3 Xerostomia; AAV-hAQP1 for the treatment of Sjogren’s Syndrome; AAV-GAD for the treatment of Parkinson’s Disease; AAV-RPE65 for the treatment of RPE65-asociated retinal dystrophy; AAV-CNGB3 and AAV-CNGA3 for the treatment of achromatopsia; AAV-AIPL1 for the treatment of LCA4, and AAV-RDH12 for the treatment of RDH12 mutation-associated retinal dystrophy.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $456.9M |
---|---|
Revenue (TTM) | $13.9M |
Shares Outstanding | 77.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-1.30 |
Book Value | $2.17 |
P/E Ratio | -4.6x |
Price/Sales (TTM) | 32.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -1,266.97% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.